4,7-Dichloro-2-hydrazino-1,3-benzothiazole, 95.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 95.0%, 10g

5-Ethynyl-dU-CEP, ≥90%, 100 mg, emballage plastique.

N-(2,4-Dichloro-phenyl)-2-hydroxy-4-methyl-benzamide, 95.0%, 1g

4-Chloro-6-methoxy-2-methyl-5-nitropyrimidine, 97.0%, 1g

1-{3-[(diethylamino)methyl]-4-hydroxyphenyl}ethan-1-one hydrochloride, 98%, 250mg

Methyl 4-Chloro-3-methylbenzoate>98.0%(GC)5g

Verres de montre, 250 mm, 5 pièce(s)

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 250mg

6-Bromo-8-chloro-2-methylimidazo[1,2-a]pyrazine, 98%, 10g

(S)-2-(Methylamino)pentanedioic acid, 95.0%, 5g

SILVER BIS(TRIFLUOROMETHANE SULFONIMIDE), 98.0%, 25g

5-Chloroquinoxaline, 95.0%, 10g